Picard Medical is trading 5.12% up at $4.72 in after-hours trading, with no clear company-specific catalyst identified for September 10, 2026.
- Recent coverage highlighted earlier second-quarter results, including 39% revenue growth, released August 19 and not new.
- The broader market was mixed: the S&P 500 fell 0.53%, while the Nasdaq Composite rose 0.08%.
- The move may reflect speculative or delayed trading activity.